Anavex Life Sciences Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 6, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Cap	332	575	359	401	600	1,016
Market Cap Growth	-43.79%	60.15%	-10.40%	-33.17%	-40.97%	382.72%
Enterprise Value	232.6	498.82	260.65	288.29	488.71	902.98
PE Ratio	-	-16.48	-10.92	-10.92	-16.65	-33.24
PB Ratio	3.53	8.13	4.00	3.79	5.65	9.04
P/TBV Ratio	3.03	8.00	3.94	3.68	5.57	8.31
P/FCF Ratio	-	-19.76	-15.63	-19.35	-33.19	-44.85
P/OCF Ratio	-	-19.76	-15.63	-19.35	-33.19	-44.85
EV/EBITDA Ratio	-	-13.01	-6.61	-6.93	-12.85	-28.82
EV/EBIT Ratio	-	-13.01	-6.61	-6.93	-12.85	-28.82
EV/FCF Ratio	-	-17.13	-11.34	-13.91	-27.03	-39.84
Net Debt / Equity Ratio	-1.04	-1.08	-1.10	-1.06	-1.05	-1.01
Net Debt / EBITDA Ratio	2.95	2.00	2.50	2.71	2.93	3.62
Net Debt / FCF Ratio	3.87	2.63	4.29	5.44	6.15	5.01
Quick Ratio	20.81	11.56	8.80	12.27	14.92	14.93
Current Ratio	20.87	11.60	8.86	12.32	14.95	14.97
Return on Equity (ROE)	-4.78%	-43.11%	-32.81%	-33.41%	-32.47%	-42.28%
Return on Assets (ROA)	-34.92%	-42.95%	-36.47%	-36.32%	-32.44%	-42.82%
Return on Invested Capital (ROIC)	672.03%	571.68%	546.90%	770.31%	1442.56%	2938.99%
Return on Capital Employed (ROCE)	-37.55%	-47.79%	-40.35%	-39.22%	-34.77%	-47.18%
Earnings Yield	-8.95%	-6.07%	-9.15%	-9.16%	-6.01%	-3.01%
FCF Yield	-	-5.06%	-6.40%	-5.17%	-3.01%	-2.23%
Buyback Yield / Dilution	-11.69%	-1.57%	-2.49%	-5.52%	-2.73%	-11.65%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.